Medicare is poised to incorporate new quality metrics as a guide for payments. At ASH 2015, the CSO of the National Quality Forum discussed the need for measures and reporting systems that reflect patient care and care coordination.
The implementation date of the International Classification of Diseases, Clinical Modification, has come and gone, and we have survived what is arguably the most significant change for providers in the history of reporting healthcare services. As the dust settles, an assessment is recommended.
The average sales price (ASP) decrease proposed by our friends at Medicare could change the face of private practice infusion suites nationwide. This would be bad for patient care; almost as importantly, this decrease would be very bad for the rheumatology business.
A presentation at the 2015 annual European Congress of Rheumatology meeting emphasized how creating electronic medical records (EMRs) for each patient and amassing “big data” derived from those records can help achieve personalized medicine.
Value-Based Care in Rheumatology asked Younger to discuss the economic implications of finding a treatment for fibromyalgia, the importance of biomarkers, and how microglial modulation could one day reverse the effects of aging.
The North American Young Rheumatology Investigator Forum (NYRIF) was established to provide clinical and research fellows in the field of rheumatology with an informal mentoring environment to share their original work.